| Literature DB >> 17511876 |
Jintae Lee1, Arul Jayaraman, Thomas K Wood.
Abstract
BACKGROUND: As a stationary phase signal, indole is secreted in large quantities into rich medium by Escherichia coli and has been shown to control several genes (e.g., astD, tnaB, gabT), multi-drug exporters, and the pathogenicity island of E. coli; however, its impact on biofilm formation has not been well-studied.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17511876 PMCID: PMC1899176 DOI: 10.1186/1471-2180-7-42
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Major components of the tryptophan pathway. Dashed lines indicate regulation.
Figure 2Intracellular and extracellular indole concentration in LB for BW25113, BW25113 trpE, BW25113 tnaC, BW25113 tnaA, and BW25113 trpL. Each experiment was performed in duplicate, and one standard deviation is shown.
Figure 3Biofilm formation in LB glu at 24 h in flow cells (A) with wild-type K-12 BW25113, (B) with wild-type K-12 BW25113 with 500 μM indole, and (C) with K-12 BW25113 trpE. Scale bar is 5 μm.
Biofilm COMSTAT flow cell measurements for E. coli BW25113 and its isogenic mutants LB glu medium at 24 h and for the dual species (E. coli/P. fluorescens) biofilm in LB medium after 5 days
| Single species of BW25113 and its isogenic mutant | BW25113 | 9 ± 5 | 8 ± 9 | 24 ± 8 | 0.6 ± 0.4 |
| BW25113 with DMF (control for indole) | 6.4 ± 3 | 6.5 ± 7 | 21 ± 8 | 0.5 ± 0.5 | |
| BW25113 with 500 μM indole | 4 ± 1.5 | 18 ± 6 | 25 ± 6 | 0.9 ± 0.6 | |
| BW25113 | 30 ± 7 | 13 ± 6 | 46 ± 3.5 | 0.3 ± 0.1 | |
| Dual species with TOM | 0.06 ± 0.05 | 0.90 ± 0.56 | 0.14 ± 0.13 | 1.97 ± 0.02 | |
| 6.63 ± 2.67 | 21.52 ± 10.49 | 13.95 ± 5.67 | 0.90 ± 0.34 | ||
| Dual species without TOM | 0.03 ± 0.01 | 0.64 ± 0.16 | 0.04 ± 0.02 | 1.99 ± 0.01 | |
| 0.56 ± 0.51 | 1.81 ± 1.23 | 1.04 ± 0.68 | 1.87 ± 0.06 | ||
Figure 4Effect of the trpE, tnaC, trpL, tnaA, sdiA, hdeA, and gadA mutations on biofilm formation in LB glu media. Biomass measured at 540 nm after 24 h. Each experiment was repeated two or four times, and one standard deviation is shown.
Figure 5Biofilm formation in LB after 5 days in flow cells for (A) dual species of E. coli K-12 XL1-Blue/pCM18 (green due to GFP) and P. fluorescens 2-79TOM/pHKT3 expressing TOM (red due to RFP), and (B) dual species of E. coli K-12 XL1-Blue/pCM18 (green due to GFP) and P. fluorescens 2-79/pHKT3 (red due to RFP). Scale bar is 10 μm.
Figure 6Effect of indole (500 μM) on the motility of BW25113 wild-type (W/T), BW25113 trpE, BW25113 tnaC, BW25113 tnaA, and BW25113 sdiA. Motility halos were measured at 8 h. Each experiment was repeated two or four times, and one standard deviation is shown. DMF (0.1 %, v/v) was used as a negative control.
Partial list of genes induced and repressed more than 2-fold after 24 h in (i) K-12 yceP biofilms upon addition of 600 μM indole in LB glu medium (experiment performed in duplicate, and one standard deviation is shown), (ii) K-12 biofilms due to the trpE mutation in LB glu medium, and (iii) K-12 biofilms due to the tnaA mutation in LB medium.
| 1.0* | 1.2 | AHL transcriptional activator (LuxR/TraR family) | 240 | |||
| 1.1* | -1.1* | hypothetical protein | 99 | |||
| -1.2 | regulation of superoxide response regulon | 107 | ||||
| 1.8 ± 0.4 | -1.2* | cold shock protein 7.4, transcriptional activator of hns | 70 | |||
| 1.3* ± 0.4 | -1.4* | MtlR transcriptional repressor | 195 | |||
| -1.1* ± 0.1 | 1.5* | D-allose kinase | 309 | |||
| -1.1* | 1.1* | rho operon leader peptide | 33 | |||
| -1.4 | -1.4 | haemolysin expression modulating protein | 72 | |||
| -1.1* | 1.0* | conserved hypothetical protein | 124 | |||
| 1.1* | 1.4 | master regulator of chemotaxis via AI-2; interacts with QseB | 98 | |||
| -1.3* ± 0.1 | 1.0* | putative fimbrial-like protein | 191 | |||
| -1.1* ± 0.1 | -1.1* | putative chaperone | 230 | |||
| -1.2* ± 0.1 | 1.1* | fimbrial assembly protein | 325 | |||
| 1.1* ± 0.1 | 1.2* | flagellar biosynthesis; assembly of basal-body periplasmic P ring | 219 | |||
| 1.1* ± 0.0 | -1.1* | hypothetical protein | 344 | |||
| 1.1* ± 0.0 | -1.7 | putative chaperone | 224 | |||
| 1.1* ± 0.1 | 1.3* | putative fimbrial-like protein | 179 | |||
| -1.2* ± 0.2 | 1.3* | YpdI colanic acid synthesis lipoprotein | 91 | |||
| -1.6 | 1.1* | activator of acid resistance genes and putative LuxR transcriptional activator | 175 | |||
| 1.2* | glutamate decarboxylase A, isozyme, PLP-dependent | 466 | ||||
| 1.2* | glutamate decarboxylase isozyme | 466 | ||||
| -1.6 | 1.2* | acid sensitivity protein, putative transporter, encoding a γ-aminobutyrate antiporter | 511 | |||
| -1.2 | -1.2 | activator of | 274 | |||
| 1.0* | periplasmic chaperone of acid-denatured protein | 110 | ||||
| 1.2* | 10K-L protein, periplasmic protein related to acid resistance protein | 112 | ||||
| -1.6 | -1.5 | protein involved in acid resistance | 190 | |||
| 1.8 ± 0.7 | 1.0* | Qin prophage; cold shock-like protein | 70 | |||
| 1.4* ± 0.2 | 1.2* | CP4-57 prophage | 109 | |||
| 1.1* ± 0.1 | 1.1* | E14 prophage | 113 | |||
| 1.0* ± 0.0 | 1.0* | Rac prophage | 119 | |||
| -1.2* ± 0.2 | 1.2* | Qin prophage | 165 | |||
| 1.0* ± 0.1 | 1.3* | Qin prophage | 255 | |||
| -1.5* ± 0.5 | 1.1* | CP4-44 prophage | 124 | |||
| 1.4* ± 0.4 | -1.1* | E14 prophage; putative tail fiber protein | 166 | |||
| 1.2* ± 0.1 | 1.1* | Rac prophage | 93 | |||
| 1.4* ± 0.4 | -1.1* | CP4-57 prophage | 567 | |||
| 1.0* ± 0.0 | -1.1* | CP4-44 prophage; putative structural protein | 122 | |||
| -1.4* ± 0.6 | 1.1* | CP4-57 prophage | 155 | |||
| 1.8 ± 0.6 | -1.9 | Rac prophage | 88 | |||
| 1.7 ± 0.0 | -1.3* | tryptophan deaminase, PLP-dependent | 476 | |||
| 1.5 ± 1.1 | 1.1* | tryptophanase leader peptide | 24 | |||
| -1.1* ± 0.1 | -1.3 | Mtr tryptophan ArAAP transporter | 414 | |||
| 1.0* ± 0.0 | -1.2* | AroP phenylalanine/tyrosine/tryptophan APC transporter | 457 | |||
| -1.2 ± 0.0 | 1.0* | pyrroline-5-carboxylate-reductase | 269 | |||
| 1.2* ± 0.1 | 1.1* | melibiose permease II | 469 | |||
| -1.2* | 1.1* | Enolase | 432 | |||
| -1.2* ± 0.2 | 1.1* | multidrug transport protein (MFS family) | ||||
| -1.1* | 1.0* | putative carboxyphosphonoenolpyruvate mutase | 296 | |||
| 1.1* | -1.2* | involved in lipopolysaccharide biosynthesis | 290 | |||
| 1.0* | 1.0* | CTP synthetase | 545 | |||
| -1.2 ± 0.1 | chorismate mutase-P-prephenate dehydratase leader peptide | 15 | ||||
| 1.5 ± 0.4 | 1.0* | cadmium-induced metal binding protein | 216 | |||
| -1.4* ± 0.4 | 1.2* | sodium-calcium/proton antiporter | 366 | |||
| -1.2* ± 0.0 | -1.4 | Na+/H antiporter, pH dependent | 388 | |||
| -1.3* ± 0.3 | -1.2* | citrate carrier | 487 | |||
| 1.1* ± 0.0 | -1.1* | integral membrane protein of SoxR-reducing complex | 193 | |||
| 1.1* ± 0.0 | 1.4* | putative diacylglycerol cholinephosphotransferase | 203 | |||
| -1.1* | 1.1* | heat shock protein, integral membrane protein | 293 | |||
| -1.9 ± 0.6 | -1.3* | S-adenosylmethionine-6-N',N'-adenosyl (rRNA) dimethyltransferase | 273 | |||
| 1.0* ± 0.1 | -1.3* | protein chain initiation factor IF-1 | 72 | |||
| 1.2* ± 0.3 | 1.1* | superoxide dismutase, manganese | 206 | |||
| 1.0* | -1.4 | hypothetical protein | 85 | |||
| 1.0* | -2.8* | maltose O-acetyltransferase | 183 | |||
| 1.1* | -2.1 | hypothetical protein | 219 | |||
| -1.1* | -1.2 | hypothetical protein | 76 | |||
| -1.5 | -1.2* | hypothetical protein | 114 | |||
| -1.3* ± 0.3 | -1.4 | hypothetical protein | 125 | |||
| -1.5* ± 0.6 | -1.4 | hypothetical protein | 70 | |||
| 1.1* ± 0.0 | 1.2* | hypothetical protein | 263 | |||
| -1.3 | hypothetical protein | 125 | ||||
| -1.1* ± 0.1 | 1.2* | hypothetical protein | 252 | |||
| -1.1* ± 0.1 | 1.0* | hypothetical protein | 156 | |||
| 1.2* ± 0.1 | -1.2* | hypothetical protein | 249 | |||
| 1.3 | 1.3 | hypothetical protein | 91 | |||
| -1.1* | -1.3 | induced by phosphate starvation; pho regulon member, requiring phoRB system | 112 | |||
| 1.1* | -1.2 | hypothetical protein | 76 | |||
| 1.2* | 1.6 | hypothetical protein | 78 | |||
| 1.3 | 1.7 | hypothetical protein | 78 | |||
| 1.2* | 1.5 | hypothetical protein | 82 | |||
| 1.1 | 1.7 | hypothetical protein | 90 | |||
| 1.2 | 1.5 | hypothetical protein, putative acid-resistance protein | 88 | |||
Full data available using GEO accession number 4562. Asterisk indicates p value greater than 0.05 (data are less reliable but included for completeness). Negative values indicate repressed genes. b # indicates the Blattner number for each gene. Boldface indicates most significant fold changes.
Figure 7Acid resistance of BW25113 wild-type (W/T) and various knockout mutants in LB medium (pH 2.5) at 37°C. Each experiment was repeated two or four times and one standard deviation is shown.
Figure 8Indole, melatonin, serotonin, epinephrine, and indole-3-acetic acid. Indole motifs are in bold.
Strains and plasmids used. AmpR, ErmR, TetR, and KmR are ampicillin, erythromycin, tetracycline and kanamycin resistance, respectively.
| [67] | ||
| K-12 Δ | [67] | |
| K-12 Δ | [67] | |
| K-12 Δ | [67] | |
| K-12 Δ | [67] | |
| K-12 Δ | [67] | |
| K-12 Δ | [67] | |
| K-12 Δ | [67] | |
| wild-type | ATCC | |
| AmpR, RFP+ | this work | |
| this work | ||
| Δ | [31] | |
| Δ | [31] | |
| [68] | ||
| [55] | ||
| wild-type | T. McDermott | |
| wild-type (NRRL B-15132) TOM- | [28] | |
| [28] | ||
| TOM+, KmR, TetR RFP+ | this work | |
| TOM-, TetR RFP+ | this work |